View Report
March 20, 2026
Measured Result 50.24 mg 100.48% of label claim
British Dragon
British Dragon
Latest Laboratory Result
50.24 mg
March 20, 2026 · 100.48% of label claim
View
Clomiphene 50 mg
Product Information
Compound Details
Active Substance
Clomiphene Citrate
Selective Estrogen Receptor Modulator (SERM)
50 mg
Strength
50 mg/tablet
Package
50 or 100 Tablets
Form
Oral Tablets
Drug Class
SERM
Selective Estrogen Receptor Modulator
Estimated Half-Life
Approximately 5–7 Days
Manufacturer
British Dragon
Amount :
50 tabs
100 tabs
Shipping :
International
U.S. Domestic
Out of stock
Product Overview
Clomiphene 50 mg by British Dragon
Clomiphene 50 mg is an oral selective estrogen receptor modulator (SERM) tablet manufactured by British Dragon and dosed at 50 mg per tablet, supplied in packs of 50 or 100 tablets.
Clomiphene Citrate Oral
Clomiphene 50 mg contains clomiphene citrate, a non-steroidal selective estrogen receptor modulator that has been used clinically for ovulation induction in women with anovulatory infertility for decades. In medical practice, clomiphene is also used off-label to treat male hypogonadism by stimulating endogenous testosterone production through the pituitary-gonadal axis.
Clomiphene works by binding to estrogen receptors in the hypothalamus and pituitary, blocking the negative feedback that estrogen normally exerts on gonadotropin-releasing hormone (GnRH) secretion. This leads to increased release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn stimulate the testes to produce more testosterone. A 2005 clinical trial demonstrated that low-dose clomiphene (25 mg daily) raised mean serum testosterone from 247.6 ng/dL to 610.0 ng/dL in hypogonadal men over 4–6 weeks.
In non-medical bodybuilding and performance-enhancement contexts, clomiphene is commonly referenced as a cornerstone of post-cycle therapy (PCT) to help restore endogenous testosterone production after suppressive anabolic steroid cycles. A case report documented successful reversal of steroid-induced hypogonadism using clomiphene at 100 mg daily for 2 months. Such use falls outside approved medical indications, though the clinical rationale is well-documented in the medical literature.
Key Properties of Clomiphene 50 mg
- Selective estrogen receptor modulator (SERM) that blocks estrogen feedback at the pituitary
- Stimulates LH and FSH release to increase endogenous testosterone production
- Clinical evidence supporting testosterone restoration in hypogonadal men
- Case reports documenting use for steroid-induced hypogonadism recovery
- 50 or 100 tablet pack sizes support extended research protocols
Product Profile
Clomiphene Citrate Profile
Clomiphene citrate is a non-steroidal SERM that acts primarily at the hypothalamic-pituitary level to modulate estrogen feedback and stimulate gonadotropin release.
Selective Estrogen Receptor Modulator (SERM)
Clomiphene is a mixture of two geometric isomers, enclomiphene and zuclomiphene, which have different pharmacokinetic and receptor activity profiles. The drug binds to estrogen receptors in the hypothalamus and pituitary, competitively inhibiting estrogen binding and reducing the negative feedback signal that suppresses GnRH secretion.
This blockade results in increased pulsatile release of GnRH, which in turn stimulates the pituitary to secrete more LH and FSH. In men, elevated LH acts on Leydig cells in the testes to increase testosterone synthesis, while FSH supports spermatogenesis. The increased testosterone production occurs through the body's natural feedback mechanisms rather than exogenous hormone administration.
Clinical research has demonstrated the efficacy of clomiphene for male hypogonadism. In a study of 36 hypogonadal men treated with 25 mg daily, mean testosterone rose from 247.6 ng/dL to 610.0 ng/dL by the first follow-up visit. A separate case report documented successful restoration of testosterone levels and pituitary-gonadal axis function in a patient with steroid-induced hypogonadism using 100 mg daily.
Clinical Status
FDA-Approved for Ovulation Induction — Used Off-Label in Men
Clomiphene is FDA-approved for ovulation induction in women with anovulatory infertility. It is used off-label in men for hypogonadism and male infertility, with clinical evidence supporting its efficacy for testosterone restoration.
Clomiphene 50 mg vs Other British Dragon Preparations
British Dragon offers several ancillary compounds used in non-medical bodybuilding contexts. Tamoxifen is another SERM commonly referenced for post-cycle therapy, while Anastrozole and Exemestane are aromatase inhibitors used to manage estrogenic side effects during cycles.
Clomiphene's distinguishing characteristic among these compounds is its dual action: blocking estrogen receptors at the pituitary while stimulating gonadotropin release, which makes it particularly suited for restoring endogenous testosterone production after suppression.
Laboratory Testing
Clomiphene 50 mg Lab Reports
Published laboratory reports for Clomiphene 50 mg are shown below with the test date, measured result and percentage of the product's 50 mg label claim.
View Report
Laboratory results apply to the specific tested sample represented in each published report and should not be interpreted as a measurement of every tablet or production batch.
Dosage & Usage
Clomiphene 50 mg Dosage & Usage
The information below is provided for educational reference only. Clomiphene is a prescription medication; medical use requires appropriate diagnosis, clinical supervision, and ongoing monitoring. Non-medical use falls outside approved indications.
Typical Dosage Ranges
In clinical practice for ovulation induction, the standard clomiphene dose is 50 mg daily for 5 days, starting on or about day 5 of the menstrual cycle. In male hypogonadism research, doses of 25 mg daily have been shown to significantly elevate testosterone, while a case report used 100 mg daily for 2 months to reverse steroid-induced hypogonadism.
| Use Case | Common Reference Range | Frequency |
|---|---|---|
| Clinical (ovulation induction) | 50 mg | Once daily for 5 days |
| Male hypogonadism (research) | 25–50 mg | Once daily |
| Non-medical PCT (reported) | 50–100 mg | Once daily for 2–6 weeks |
These non-medical ranges represent community-reported practices and are not derived from controlled clinical trials for performance enhancement. Individual response to clomiphene varies based on baseline hormone levels and the degree of axis suppression.
Stacking & Cycle Considerations
In non-medical bodybuilding contexts, clomiphene is typically used as a standalone PCT compound rather than being stacked with other agents. It is commonly referenced alongside Tamoxifen as an alternative SERM, with some protocols describing the use of one or the other rather than both simultaneously.
Clinical research supports the use of clomiphene for restoring the pituitary-gonadal axis after suppression. PCT protocols typically begin after the last anabolic steroid dose has cleared the system, with duration based on cycle length and compounds used.
Managing Side Effects
Common side effects reported in clinical trials include ovarian enlargement (13.6%), vasomotor flushes (10.4%), abdominal discomfort (5.5%), nausea and vomiting (2.2%), and breast discomfort (2.1%). Visual disturbances including blurred vision, floaters, and photophobia have been reported, and patients experiencing visual symptoms should discontinue treatment.
Serious adverse events reported post-marketing include thromboembolic events, pancreatitis, hepatic transaminase elevation, and psychiatric symptoms including anxiety and mood changes. Clomiphene is contraindicated in pregnancy (Category X) and should be used with caution in patients with a history of thrombophlebitis or hepatic disease.
Important
Individual Response Varies
Clomiphene has approved dosing for specific medical indications. Any information about non-medical use is derived from user-reported practices and is not validated by controlled clinical research. This information does not constitute medical advice.
Safety & Information
Clomiphene Citrate Safety Information
Clomiphene is a prescription medication with known risks that require clinical oversight. It is contraindicated in pregnancy and certain medical conditions.
Important Safety Information
Clomiphene citrate is classified as Pregnancy Category X and is contraindicated in pregnant women. It should not be used in patients with hypersensitivity to clomiphene, hepatic impairment, abnormal uterine bleeding, uncontrolled thyroid or adrenal dysfunction, or a history of ovarian cysts not related to polycystic ovary syndrome.
Visual symptoms have been reported with clomiphene use, including blurred vision, floaters, photophobia, and scotomata. Patients experiencing any visual disturbance should discontinue treatment and undergo prompt ophthalmological evaluation.
Important
Non-Medical Use
Non-medical use of clomiphene falls outside approved indications. Product purity does not establish that non-medical use is safe or appropriate for an individual. Clomiphene should be used under medical supervision.
Potential Adverse Effects
Common adverse reactions (incidence ≥1%) include ovarian enlargement (13.6%), vasomotor flushes (10.4%), abdominal-pelvic discomfort (5.5%), nausea and vomiting (2.2%), breast discomfort (2.1%), and visual complaints including blurred vision, floaters, and photophobia.
Serious adverse events reported post-marketing include deep vein thrombosis, pulmonary embolism, pancreatitis, hepatic transaminase elevation, and psychiatric symptoms including anxiety, irritability, and psychosis. Ovarian hyperstimulation syndrome (OHSS) has been reported and can progress rapidly within 24 hours.
Prolonged clomiphene use may elevate serum desmosterol levels due to interference with cholesterol synthesis, though sterol levels are not significantly altered at recommended doses.
Conditions Requiring Medical Evaluation
Clomiphene is not appropriate for everyone. Contraindications include pregnancy, breastfeeding, history of hepatic impairment, abnormal uterine bleeding, uncontrolled adrenal dysfunction, non-PCOS-related ovarian cysts, organic intracranial lesions, uncontrolled thyroid disease, pituitary tumor, and endometrial cancer.
Caution is advised in patients with a history of thrombophlebitis or thromboembolic events, as case reports describe deep vein thrombosis following clomiphene treatment. Fasting lipid panel monitoring is recommended for patients at risk of hypertriglyceridemia.
Monitoring During Therapy
Medically supervised clomiphene therapy may involve pregnancy testing and pelvic examination before each treatment cycle. In male hypogonadism research, serum testosterone, LH, and FSH levels are typically monitored to assess response and guide dosing. Any visual symptoms warrant immediate discontinuation and ophthalmological evaluation.
Product Care
Storage & Handling
Store tablets in a cool, dry place in the original packaging. Keep out of reach of children. Inspect tablets before use and do not use if they appear damaged or compromised.
Further Safety Information
Shipping & Authenticity
Shipping & Product Authenticity
Clomiphene 50 mg is supplied through the official British Dragon distribution chain and shipped in original manufacturer packaging with discreet, privacy-focused handling.
USA Domestic 3–5 business days
International 10–15 business days
Order Processing 24–48 business hours
Tracking Provided after dispatch
Direct Supply
Discreet Delivery & Original Packaging
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details. Products are supplied through the official British Dragon distribution chain.
What to Expect
- Orders are processed after payment confirmation
- USA Domestic shipping is typically faster when local stock is selected
- International orders include tracking, though update frequency may vary by destination
- Multiple warehouses may result in separate shipments when applicable
Authenticity Verification
To verify your Clomiphene 50 mg product, use the security code on the packaging and cross-check it on the British Dragon official site. Official British Dragon presentation and original packaging help reinforce product legitimacy and buyer confidence.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Storage
Clomiphene 50 mg Storage
Proper storage conditions help preserve tablet stability and overall product integrity throughout shelf life.
Recommended Conditions
Store at controlled room temperature (15–25°C) in a cool, dry place, away from direct light and moisture. Keep tablets in their original blister packaging or container until use to protect from humidity.
Inspect tablets before use and do not use if they appear discolored, cracked, or otherwise compromised. Keep out of reach of children.
Quick Reference
Do & Don't
- Do store at 15–25°C
- Do keep in original packaging
- Do inspect before each use
- Don't expose to direct sunlight or moisture
- Don't store in bathroom or humid areas
- Don't use if tablets appear abnormal
Frequently Asked Questions
Clomiphene 50 mg FAQ
Answers to common questions about Clomiphene 50 mg, the Clomiphene Citrate compound, and its applications.
What is Clomiphene 50 mg used for?
Clomiphene 50 mg contains the SERM clomiphene citrate. In clinical medicine, it is approved for ovulation induction in women with anovulatory infertility. It is also used off-label to treat male hypogonadism by stimulating endogenous testosterone production. In non-medical bodybuilding contexts, it is commonly referenced as a post-cycle therapy (PCT) compound, though such use falls outside approved indications.
How often should Clomiphene 50 mg be taken?
The clinical dose for ovulation induction is 50 mg daily for 5 days. In male hypogonadism research, doses of 25 mg daily have been used, while a case report used 100 mg daily for 2 months. In non-medical PCT contexts, community-reported protocols typically reference 50–100 mg daily for 2–6 weeks. These non-medical practices are not derived from controlled clinical trials.
Does Clomiphene 50 mg require PCT?
Clomiphene is itself used as a post-cycle therapy (PCT) compound rather than requiring PCT after use. It is not an anabolic steroid and does not suppress endogenous testosterone production. Instead, it stimulates LH and FSH release to help restore the pituitary-gonadal axis after suppression.
What does Clomiphene Citrate do?
Clomiphene is a selective estrogen receptor modulator that binds to estrogen receptors in the hypothalamus and pituitary, blocking estrogen's negative feedback on GnRH secretion. This leads to increased LH and FSH release, which in turn stimulates testosterone production in men. A clinical study demonstrated that 25 mg daily raised mean testosterone from 247.6 ng/dL to 610.0 ng/dL in hypogonadal men.
How long does Clomiphene take to work?
In clinical research, significant increases in testosterone were observed by the first follow-up visit at 4–6 weeks of daily clomiphene use. A case report documented normalization of testosterone levels with 2 months of treatment at 100 mg daily. Ovulation typically occurs 5–10 days after a 5-day course in women.
Is Clomiphene the best SERM for PCT?
There is no universally established "best" SERM, and clomiphene has not been validated in controlled trials specifically for post-steroid-cycle recovery. However, clinical evidence supports its efficacy for restoring testosterone in hypogonadal men, and a case report documents successful use after steroid abuse. Tamoxifen is an alternative SERM commonly referenced in PCT contexts.
What is the difference between Clomiphene and Tamoxifen?
Clomiphene and Tamoxifen are both SERMs but have different receptor activity profiles and clinical applications. Clomiphene is primarily used for ovulation induction and has documented efficacy for male hypogonadism. Tamoxifen is used in breast cancer treatment and is also referenced in non-medical PCT contexts. Their side effect profiles differ.
What is the difference between Clomiphene and Anastrozole?
Clomiphene and Anastrozole have different mechanisms. Clomiphene is a SERM that blocks estrogen receptors at the pituitary to stimulate LH/FSH release and testosterone production. Anastrozole is an aromatase inhibitor that reduces estrogen synthesis by blocking androgen-to-estrogen conversion. They are used for different purposes in non-medical contexts.
Is 50 mg of Clomiphene a lot?
Clomiphene 50 mg is labeled at 50 mg of clomiphene citrate per tablet. This is the standard clinical dose for ovulation induction and is within the range used in male hypogonadism research. In non-medical PCT contexts, 50 mg is commonly referenced as a standard daily dose.
What strength is Clomiphene 50 mg?
Clomiphene 50 mg is labeled at 50 mg of clomiphene citrate per tablet. It is supplied as oral tablets in packs of 50 or 100 tablets manufactured by British Dragon.
Is Clomiphene 50 mg lab tested?
Yes. A published laboratory report dated March 20, 2026 measured Clomiphene 50 mg at 50.24 mg, equivalent to 100.48% of its 50 mg label claim. The complete report can be viewed in the Lab Reports tab.
Related Offers
British Dragon Pharmaceuticals
Product Information Compound Details
Active Substance Anastrozole Nonsteroidal Aromatase Inhibitor
1 mgStrength 1 mg/tablet
Package 50 or 100 Tablets
Form Oral Tablets
Drug Class Aromatase Inhibitor
Inhibitor Type Nonsteroidal
Manufacturer British Dragon
British Dragon Pharmaceuticals
Product Information Compound Details
Active Substance Oxandrolone Anavar · 17α-Alkylated Oral Anabolic Steroid
10 mgStrength 10 mg/tablet
Package 100 Tablets 1,000 mg Total Labeled Content
Form Oral Tablets
Drug Class Anabolic-Androgenic Steroid
Estimated Half-Life Approximately 9–10 Hours
Manufacturer British Dragon
Lab Tested
British Dragon Pharmaceuticals
Product Information Compound Details
Active Substance Testosterone Enanthate Long-acting testosterone ester
250 mg/mLStrength 250 mg/mL
Package 10 mL Vial 2,500 mg total labeled content
Form Oil-Based Injectable
Estimated Half-Life Approximately 7–9 Days
Drug Class Androgen & Anabolic Steroid
Manufacturer British Dragon
British Dragon Pharmaceuticals
Product Information
Compound Details
Active Substance
Tamoxifen Citrate
Selective Estrogen Receptor Modulator (SERM)
20 mg
Strength
20 mg/tablet
Package
50 or 100 Tablets
1,000 mg or 2,000 mg Total Labeled Content
Form
Oral Tablets
Drug Class
SERM
Selective Estrogen Receptor Modulator
Estimated Half-Life
Approximately 5–7 Days
Manufacturer
British Dragon